Eton Pharmaceuticals, Inc. has grown revenue 54% a year over three years and 360% a year over five. Revenue growth, 3-year annual rate: +54% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +360%, growth has slowed since the five-year average. Years of annual history on file: 8, FY2018 to FY2025, as filed.

ETONEton Pharmaceuticals, Inc.

Healthcare

$54.73+159% 1Y

$54.73

$14.3552 weeks$64.38

Is it growing?

Good

Growing: revenue growing +81% year on year and operating margin widening (+12.4 points).

2 good, 1 without data

Revenue trend+81% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+12.4 points operating

Trailing-twelve-month operating margin, 12.4% now against -0.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ETON growing?

Eton Pharmaceuticals, Inc. has grown revenue 54% a year over three years and 360% a year over five.

+54%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +360%
Revenue growth, 5-year rate · +54% over three · growth has slowed since the five-year average
Years of annual history on file: 8
Years of annual history on file · FY2018 to FY2025, as filed

Details›